Article

Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype delta F508/S1215N

2015-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9c3eb4e7-194c-5de1-afa2-5eb4cba9f505
DOI: 10.1186/2045-7022-5-s4-p2
PMCID: PMC4493608

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype delta F508/S1215NDOI 10.1186/2045-7022-5-s4-p2Read

Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215N.Semantic proximity Read

Ivacaftor in a G551D homozygote with cystic fibrosis.Semantic proximity Read

Positive clinical outcomes following ivacaftor treatment in a cystic fibrosis patient with the genotype 3272-26A > G/Q493X.Semantic proximity Read

Ivacaftor for cystic fibrosis.Semantic proximity Read

The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients.Semantic proximity Read

The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis.Semantic proximity Read

Lumacaftor/ivacaftor (Orkambi) for cystic fibrosis.Semantic proximity Read

Is Elexacaftor/Tezacaftor/Ivacaftor Effective in Treating Sinonasal Disease in Patients with Cystic Fibrosis?Semantic proximity Read

Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or functionSemantic proximity Read

Effects of Ivacaftor in Three Pediatric Siblings With Cystic Fibrosis Carrying the Mutations G551D And F508del.Semantic proximity Read

A safety evaluation of ivacaftor for the treatment of cystic fibrosis.Semantic proximity Read

Improvement in sinonasal quality-of-life indicators for pediatric patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.Semantic proximity Read